IL26 and neoplasm: Moreover, tumor growth was significantly decreased in TNBC transplanted in hIL-26Tg mice following administration of anti-IL-26 mAb and gefitinib (green line in Fig. 6C), compared to that seen with control mAb and gefitinib (pale blue line in Fig. 6C).